1/114
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
all
Symptom management is appropriate in _______ patients.
rest and hydration
What should you recommend for muscle aches or general malaise?
-warm liquids
-gargle warm salt water
What can you recommend for sore throat?
-saline nasal spray or rinse
-humidifier or warm showers
-nasal strips
What can you recommend for congestion?
Dextromethorphan
-only single cough suppressant agent available
-no recommended < 4 yrs old
all
What cough suppressants have abuse potential?
Guaifenesin
-only single agent available for expectorant
-not recommended in < 4 yrs old
-ER forms not recommended in <12 yrs old
no
Are expectorants effective in nonproductive "dry" coughs?
analgesics/antipyretics
-OCTs NSAIDs, tylenol, aspirin
aspirin
should be avoided in peds
ibuprofen
should be avoided in < 6 months of age
NSAIDs
should be avoided in the 3rd trimester of pregnancy
decongestants
-Causes vasoconstriction (caution in cardiovascular disease)
-Phenylephrine has poor oral absorption
-Avoid in children < 2 years of age
throat spray/lozenge
-Can minimize sore throat symptoms
-Throat sprays often contain anesthetics with numbing properties (avoid in children < 6 years of age)
-Lozenges avoid in children < 5 years of age (choking hazard)
anti-histamines
-Can be effective if typical allergy symptoms (e.g. itchy eyes, runny nose) are present
-First generation (diphenhydramine, doxylamine) or second generation (cetirizine, loratadine, fexofenadine)
-Avoid first generation agents in geriatric populations
risk factors for severe disease in covid
⢠℠65 years of age
⢠male
⢠presence of at least one underlying medical condition
⢠unvaccinated individuals
s/s of covid
sore throat, headache, runny nose, cough, fever and/or chills, fatigue, muscle/body aches, gastrointestinal distress, shortness of breath, loss of taste or smell, sputum production
mild to moderate covid
SpO2 ā„ 94% on room air and not needing supplemental oxygen with risk factors for progression to severe disease, hospitalization or death
severe but not critical covid
SpO2 < 94% on room air or needing low flow supplemental oxygen
critical covid
-needing high flow oxygen/or non invasive ventilation
-needing mechanical ventilation or ECMO
Paxlovid (Nirmatrelvir and Ritonavir)
for ambulatory adults and peds pts (ā„ 12 yrs old and more than 40 kg) with mild to moderate covid at high risk for progression
within 5 days.
When do you have to give paxlovid?
300mg/100mg po q12h for 5 days
What is the dosing of paxlovid?
yes
Does paxlovid have renal dose adjustments?
Paxlovid AEs
-dysgeusia
-diarrhea
DDIs with paxlovid
-strong CYP3A4
-P-gp inhibitor
statins
What drugs should you hold when starting paxlovid?
lagevrio (molnupiravir)
for ambulatory adults with mild-to-moderate COVID-19 at high risk for progression without other therapy options
within 5 days
When do you have to start lagevrio?
800 mg po bid for 5 days
What is the dosing of lagevrio?
Lagevrio AEs
diarrhea and nausea
may halt bone growth
Why is lagevrio not authorized in pregnancy and children?
veklury
for ambulatory or hospitalized adults and pediatric patients ā„ 12 years of age & ā„ 40 kg with mild-to-moderate COVID-19 at high risk for progression
within 7 days of symptom onset
When do you have to start veklury?
200 mg IV on day 1, following by 100 mg IV once daily
What is the dosing of veklury for adults?
5 mg/kg IV on day 1, then 2.5 mg/kg IV once daily
What is the dosing of Veklury for peds?
3-5 days
How long is the Veklury course of therapy?
Veklury (Remdesivir) AEs
-elevated LFTs
-infusion reactions
-bradycardia
-hypotension
dexamethasone
for severe or critically ill hospitalized pts with covid
6 mg daily for 10 days or until discharge
What is the dosing of dexamethasone for covid?
AEs of Dexamethasone
fluid retention, hyperglycemia, hypertension, behavioral changes, increased appetite and weight gain
with food
What should you take with oral formulations of dexamethasone?
JAK Inhibitors: OlumiantĀ® (baricitinib)& XeljanzĀ® (tofacitinib)
hospitalized adults with severe COVID-19 in combination with steroids (if you cant take steroids then take remdesivir with it)
4 mg po qd
What is the dosing of baricitinib?
10 mg po bid
What is the dosing of tofacitinib?
up to 14 days or until hospital discharge
What is the duration of dosing for JAK Inhibitors: OlumiantĀ® (baricitinib) & XeljanzĀ® (tofacitinib)?
renal and hepatic
Are there dose adjustments for JAK Inhibitors: OlumiantĀ® (baricitinib)& XeljanzĀ® (tofacitinib)?
BBW of JAK Inhibitors: OlumiantĀ® (baricitinib)& XeljanzĀ® (tofacitinib)
Serious infections, all-cause mortality, malignancies (lung and lymphoma), major adverse cardiovascular events (MACE), and thrombosis
GI perforation and pregnancy
What type of pts should you AVOID use of JAK Inhibitors: OlumiantĀ® & XeljanzĀ®?
AK Inhibitors: OlumiantĀ® & XeljanzĀ® AEs
increased LFTs, thrombocytosis, thrombosis, neutropenia, urinary tract infections, and creatinephosphokinase elevations
do not initiate Olumiant or Xelijanz
⢠ANC < 1,000/mm3
⢠Lymphocytes <500/mm3
⢠Hemoglobin < 9 g/dL (Xeljanz®) or <8 g/dL (Olumiant®)
IL-6 Inhibitors: ActemraĀ® (tocilizumab)& KevzaraĀ® (sarilumab)
Among hospitalized adults with progressive severe or critical COVID-19 who have elevated markers of systemic inflammation in combination with steroids
8 mg/kg IV once (maxdose 800 mg); can consider 2nd dose 8 hours+ after initial
What is the dosing of Tocilizumab?
400 mg IV once
What is the dosing of Sarilumab?
inflammatory markers of IL-6
Systemic inflammation: C-reactive protein ā„ 75 mg/dL
BBW of Actemra andKevzara
serious infections
GI perforation
You should avoid Actemra and Kevzara in pts with what?
Actemra
should be avoided in pregnancy
AEs of IL-6 inhibitors (Actemra and Kevzara)
increased LFTs, neutropenia, urinary tract infections, and injection site reactions
do not initiate IL-6 inhibitors
⢠ANC < 2,000/mm3
⢠Platelets <150,000/mm3
⢠ALT/AST > 1.5 times ULN
Pemgarda (pemivibart)
-used for PREVENTION of covid in moderately or severely immunocompromised patients ā„12 years of age and ā„ 40 kg
-pts who have high risk of progression to severe covid without exposure
4.5 g IV as a single dose; may repeat dose every 3 months
What is the dosing of Pemgarda (pemivibart)?
at least 2 weeks after vaccine is recieved
When is pemgarda (pemivibart) given?
AEs of pemgarda (pemivibart)
infusion reactions, fatigue, headache, nausea, upper respiratory tract infection
Pemgarda (Pemivibart) BBW
anaphylaxis - monitor for at least 2 hours after infusion
risk factors for severe flu
-older adults (ā„65 years)
-children < 2 years
-those with underlying conditions
s/s of flu
-rapid onset of fever, myalgia, headache, malaise, nonproductive cough, sore throat, and rhinitis
-children - nausea, vomiting, otitis media
ppl who get flu tx
-Hospitalized patients
- Severe or progressive illness
- High risk of complications
- Immunosuppressed
- Multiple chronic conditions
- Pregnant women or within 2 weeks postpartum
- Children < 2 years of age
-Adults ā„65 years
ppl who should get chemoprophylaxis for flu
-Unvaccinated individuals with high risk of complications
- Severely immunocompromised
- Short-term for unvaccinated individuals in close contact with high risk individuals
neuraminidase inhibitors
-Oseltamivir (TamifluĀ®)
-Zanamivir (RelenzaĀ®)
-Peramivir (RapivabĀ®)
polymerase acidic endonuclease inhibitors
baloxavir (Xofluza)
within 48 hours of symptom onset
When should flu meds be started?
Oseltamivir tx dose
75 mg PO BID x 5 daysIndicated for patients ā„14 days old
Oseltamivir prophylaxis dose
75 mg PO daily x 10 days Indicated for patients ā„3 months old
zanamivir tx dose
2 puffs BID x 5 days Indicated for patients ā„7 years old
zanamivir prophylaxis dose
2 puffs daily x 10 days Indicated for patients ā„5 years old
peramivir dosing
600 mg IV dose once over 15-30 minutes Indicated for patients ā„5 years old
AEs of Oseltamivir
-nausea/vomiting
-post-marketing:serious skin reactions & neuropsychiatric events
AEs of Zanamivir
sore throat, bronchospasm, sinusitis
Peramivir AEs
-diarrhea
-post-marketing: serious skin reactions & neuropsychiatric events
ozeltamivir (Tamiflu)
requires renal dose adjustments
zanamivir (Relenza)
-avoid in those with dairy allergies
-avoid in those with underlying airway disease
peramivir (Rapivab)
-ideal for those who cannot take oral or inhaled therapies
-requires renal dose adjustments
2 mg/kg qd
What is the dose of baloxavir (Xofluza) for <20 kg?
40 mg po qd
What is the dose of baloxivir (Xofluza) for 20-80 kg?
80 my po qd
What is the dose of baloxivir (Xofluza) for > 80 kg?
AEs of Xofluza
-D
-V
polyvalent cations (electrolytes)
What are the DDIs with Xofluza?
uncomplicated flu infections
Xofluza is indicated in what type of flu infection?
> 5
How old do you have to be to get Xofluza?
October through march
What is the "RSV season"?
RSV
-most common cause of lower respiratory tract infections in elderly and infants
-no available antiviral therapies for tx
risk factors for severe RSV
⢠℠75 years of age
⢠immunosuppressed patients
⢠history of cardiac or pulmonary diseases
⢠preterm birth
⢠< 6 months during RSV season
s/s of RSV
nasal congestion, rhinorrhea, cough, fever, sore throat, headache
s/s of severe RSV
tachypnea, dyspnea, wheezing, hypoxia, cyanosis
Beyfortus (Nirsevimab)
-<8 months: born to an unvaccinated pregnant parent during or entering their first RSV season
- 8-19 months: at increased risk of severe RSV disease and entering their second RSV season including:
- Chronic lung disease requiring medical support
(e.g. corticosteroids, diuretics, or oxygen therapy)
- Cystic fibrosis with severe lung disease manifestations
- Severely immunocompromised
- Can still be administered if < 5 doses of Synagis was administered during RSV season
Beyfortus (nirsevimab) MOA
monoclonal antibody that acts on the F protein on the surface ofRSV to inhibit fusion of the virus to the cell membrane
50 mg IM once
What is the dosing of Beyfortus (nirsevimab) for pts < 5 kg?
100 mg IM once
What is the dosing of Beyfortus (nirsevimab) for pts > or = 5 kg?
warning of beyfortus (nirsevimab)
caution in those with a bleeding disorder